ページを読み込んでいます…
ページを読み込んでいます…
財務データが揃わず、性格の分類はしていない
候補薬は事実上Aramchol一つで、適応だけを何度も差し替えて延命させてきた。複数の候補を並べて確率を分散する創薬企業とは、賭け方が根本から違う。
製品の売上はまだ一つもない。収入として立つのは、韓国のSamilへ導出した契約の一時金を期間に割り振った分と、将来入るかもしれないロイヤルティやマイルストーンだけだ。
脂肪肝炎と原発性硬化性胆管炎では承認まで届かず、累積損失は$210.8Mに積み上がった。狙いを変えたがん領域で同じ結果になれば、25年分の投資が回収できないまま残る。
2024年3月に本社の賃貸契約が切れたあと更新せず、いまはMeitar法律事務所の住所を登記に使っている。固定費を削り切って、資金を試験に回す構えを取る。
Aramcholをがん領域で前へ進められるかに、会社の値打ちのほとんどが乗っている。2025年末の手元は現預金$4.0Mを含めて$18.3Mで、試験を何本走らせられるかはこの範囲で決まる。
登記上の本社は、ラマトガンにある法律事務所の中にある。2024年3月に前の事務所の賃貸契約が切れたあと更新せず、新しい場所を探している最中だとだけ書かれている。
会社が持つ候補薬は事実上Aramchol一つで、2000年から数えて25年、適応を替えながら開発を続けてきた。脂肪肝炎と胆管の病では承認に届かず、累積損失$210.8Mを抱えたまま、いまはがん領域に望みをつないでいる。
この銘柄は SEC の米ドル建て年次データが取得できないため、財務の数字を表示していません。 外国企業などで決算を米ドル以外の通貨で開示している場合、通貨を取り違えたまま 載せるより表示しない方が誠実だと考えています。原文は下の関連タブから SEC EDGAR で確認できます。
従業員数は在籍する人数、採用人数は年度中に新しく採用した人数です。年度は会社ごとの会計年度で、会社(発行体)単位の開示値を掲載しています。
従業員数 5/5年度・採用人数 0/5年度に数値あり。 未確認は0人を意味せず、非開示は会社が開示しないと明示した項目です。
| 会計年度 | 従業員数 | 年間採用人数 |
|---|---|---|
| 2021 | 24人雇用形態の区分未確認 | 未確認 |
| 2022 | 10人雇用形態の区分未確認 | 未確認 |
| 2023 | 8人雇用形態の区分未確認 | 未確認 |
| 2024 | 6人雇用形態の区分未確認 | 未確認 |
| 2025 | 6人雇用形態の区分未確認 | 未確認 |
FTEは労働時間を常勤換算した値です。常勤のみ・年平均などの定義、単体・連結の範囲、買収による変化は年度で異なる場合があります。5年分の数値があっても、同じ条件で比較できるとは限りません。
f the Board,” we do not have written agreements with any director providing for benefits upon the termination of his or her services with our Company. D. Employees. As of December 31, 2021, we had 24 employees, of which 19 were full-time employees and 5 were part-time employees. 18 of the Company’s employees were involved in our clinical and product develop
f the Board,” we do not have written agreements with any director providing for benefits upon the termination of his or her services with our Company. D. Employees. As of December 31, 2022, we had 10 employees, of which 4 were full-time employees and 6 were part-time employees. 5 of the Company’s employees were involved in our clinical and product developme
ive Officer and Chairman of the Board,” we do not have written agreements with any director providing for benefits upon the termination of his or her services with our Company. 114 D. Employees. As of December 31, 2023, we had eight employees, of which three were full-time employees and five were part-time employees. Four of our employees were involved in our clinical and product development operations and 4 served in general and administrative capacities. While none of our employees are party to any collective bargaining agreements or represented by any labor unions, certain provisions of the Israeli labor laws and certain collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations (including the Industrialists’ Associations) are applicable to our employees by order of the Israel Ministry of
ecutive Officer and Chairman of the Board,” we do not have written agreements with any director providing for benefits upon the termination of his or her services with our Company. D. Employees. As of December 31, 2024, we had six employees, of which three were full-time employees and three were part-time employees. Three of our employees were involved in our clinical and product development operations and three served in general and administrative capacities. While none of our employees are party to any collective bargaining agreements or represented by any labor unions, certain provisions of the Israeli labor laws and certain collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations (including the Industrialists’ Associations) are applicable to our employees by order of the Israel Minis
ecutive Officer and Chairman of the Board,” we do not have written agreements with any director providing for benefits upon the termination of his or her services with our Company. D. Employees. As of December 31, 2025, we had six employees, of which three were full-time employees and three were part-time employees. Three of our employees were involved in our clinical and product development operations and three served in general and administrative capacities. 111 While none of our employees are party to any collective bargaining agreements or represented by any labor unions, certain provisions of the Israeli labor laws and certain collective bargaining agreements between the Histadrut (General Federation of Labor in Israel) and the Coordination Bureau of Economic Organizations (including the Industrialists’ Associations) are applicable to our employees by order of the Israel M
ログイン状態を確認しています…
読み込み中…